Skip to main content

noComment
Swine flu gives Sanofi a shot in the arm

corporate

| |

French drugmaker Sanofi-Aventis has swine flu to thank for an improved outlook for 2009. The group said it expected H1N1 vaccines to add around 337 million euros to sales in the fourth quarter alone and sees that continuing into next year. Its earnings per share for the quarter just gone increased over 16 percent on the back of cost cutting measures.

More about: ,

Copyright © 2012 euronews

| |

Login

Please enter your login details

Join the euronews community

By joining euronews’ community , you can participate to U talk and I talk and subscribe to our newsletters.
Please note: All fields are required